American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on September 8, 2026

Sep. 8, 2026

Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026

Indeterminate GlobeNewswire

Sep. 8, 2026

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

Indeterminate GlobeNewswire

Sep. 8, 2026

Newcore Gold Announces Appointment of Mr. Sulemanu Koney to its Board of Directors

Indeterminate GlobeNewswire

Sep. 8, 2026

Generate Biomedicines Inc. to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire

Sep. 8, 2026

Lantronix CEO to Participate in Upcoming Investor and Industry Events

Indeterminate GlobeNewswire

Sep. 8, 2026

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire

Sep. 8, 2026

Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics

Indeterminate GlobeNewswire

Sep. 8, 2026

G3 Goldfields Provides Update on Listing

Indeterminate GlobeNewswire

Sep. 8, 2026

CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire

Sep. 8, 2026

Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire

Sep. 8, 2026

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire

Sep. 8, 2026

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

Indeterminate GlobeNewswire

Sep. 8, 2026

NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director

Indeterminate GlobeNewswire

Sep. 8, 2026

Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026

Indeterminate GlobeNewswire